Active ingredient : Ibrutinib Ibrutinib
Imbruvica is a prescription medication that contains the active ingredient Ibrutinib, a targeted therapy designed to treat certain types of blood cancers. It is particularly effective for patients diagnosed with chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), and other hematologic malignancies.
Couldn't load pickup availability
Free shipping and returns available on all orders!
We ship all US domestic orders within 5-10 business days
Imbruvica is an oral medication that contains the active ingredient Ibrutinib, a targeted therapy used primarily for the treatment of certain types of blood cancers, including chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL). It works by inhibiting a specific protein that promotes cancer cell growth, thereby helping to slow down or stop the progression of the disease.
Imbruvica is indicated for the treatment of:
The recommended dosage of Imbruvica is 140mg taken orally once daily. It is important to take the medication at the same time each day, with or without food. Patients should follow their healthcare provider's instructions regarding dosage adjustments and duration of treatment.
Common side effects of Imbruvica may include:
Patients should report any severe or persistent side effects to their healthcare provider.
Before starting Imbruvica, patients should inform their healthcare provider of any pre-existing conditions, especially:
Imbruvica may interact with other medications, so it is essential to discuss all current medications with a healthcare provider.
Store Imbruvica at room temperature, away from moisture and heat. Keep out of reach of children and pets.
Imbruvica (Ibrutinib) offers an effective treatment option for patients with specific types of blood cancers. With proper medical guidance, it can help manage symptoms and improve quality of life.